Drug Type Chemical drugs |
Synonyms Plant-derived BDNF/TrkB modulators, AXN 001, AXN001 |
Target |
Mechanism BDNF modulators(Brain-derived neurotrophic factor modulators), TrkB modulators(Neurotrophic tyrosine kinase receptor type 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | MU | 29 Aug 2024 | |
Alzheimer Disease | Preclinical | MU | 29 Aug 2024 | |
Parkinson Disease | Preclinical | MU | 29 Aug 2024 | |
Parkinson Disease | Preclinical | MU | 29 Aug 2024 |